Home
About
Services
Partners
Client Portfolio
News
Contact
U.S. sanctions Russian, Chinese tech firms over funds for North Korea
September 14, 2018
Deutsche Bank’s retreat to Germany gets tepid welcome at home
September 14, 2018
0
Takeda gets China’s approval for $62 billion Shire purchase
Published by
Muller&Green
at
September 14, 2018
Categories
RSS
Tags
Takeda Pharmaceutical Co Ltd said on Friday China approved its purchase of Shire Plc, the latest regulator to clear the $62 billion deal and bring the Japanese group closer to becoming a global top 10 drugmaker.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more